ARCHIVES

FDA Opponents Claim Abuses; Agency Doesn’t Attend Hearing

This article is from The Cancer Letter archive.

Vol. 21 No. 30 | July 28, 1995

Download PDF Visit The Full Archive

Related Articles

DCT Board Approves Recommendations For Clinical Trials; Some Controversial

November 9, 1979

NCI Begins Phase III Trial Of Shark Cartilage In NSCLC.

May 25, 2001

AACR Presents 2014 Awards, Arteaga Becomes President at Annual Meeting

April 11, 2014

Commission Urges Bypass Funding for Breast Cancer

November 5, 1993

Acceptance Of Sentinel Node Biopsy Is Growing, Study Finds

October 31, 2003

NCI Invites “Extraordinary Opportunities” For Research. Groups Planning Promotion Of Cancer Clinical Trials.

May 4, 2001